CD276 and ovarian cancer: Fold NK cell activation against all ovarian cancer cell lines, calculated as activation on PBMC+Tumor+TriKE divided by activation on PBMC+TriKE alone, was higher than activation by the B7-H3-negative Raji line (Figure S2F), indicating the B7-H3 specificity of the TriKE.